Your browser doesn't support javascript.
loading
Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program.
Kanda, Yoshinobu; Doki, Noriko; Kojima, Minoru; Kako, Shinichi; Inoue, Masami; Uchida, Naoyuki; Onishi, Yasushi; Kamata, Reiko; Kotaki, Mika; Kobayashi, Ryoji; Tanaka, Junji; Fukuda, Takahiro; Fujii, Nobuharu; Miyamura, Koichi; Mori, Shin-Ichiro; Mori, Yasuo; Morishima, Yasuo; Yabe, Hiromasa; Atsuta, Yoshiko; Kodera, Yoshihisa.
Affiliation
  • Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan. Electronic address: ycanda-tky@umin.ac.jp.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Kojima M; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Kako S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Inoue M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Onishi Y; Department of Hematology, Tohoku University Hospital, Sendai, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Kamata R; Nonprofit Organization Blood Disorder Information and Support Service "Tsubasa", Tokyo, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Kotaki M; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Kobayashi R; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Tanaka J; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Fujii N; Division of Blood Transfusion, Okayama University Hospital, Okayama, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Miyamura K; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Mori SI; Hematology Department, St. Luke's International Hospital, Tokyo, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Mori Y; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Morishima Y; Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Yabe H; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan; Medical Committee of the Japan Marrow Donor Program, Tokyo, Japan.
  • Kodera Y; Aichi Medical University School of Medicine, Aichi, Japan.
Transplant Cell Ther ; 28(10): 677.e1-677.e6, 2022 10.
Article in En | MEDLINE | ID: mdl-35803526
During the COVID-19 pandemic, donor grafts are frequently cryopreserved to ensure that a graft is available before starting a conditioning regimen. However, there have been conflicting reports on the effect of cryopreservation on transplantation outcomes. Also, the impact of cryopreservation may differ in bone marrow (BM) transplantation (BMT) and peripheral blood stem cell (PBSC) transplantation (PBSCT). In this retrospective study, we analyzed the clinical data of both cryopreserved unrelated BMTs (n = 235) and PBSCTs (n = 118) and compared these with data from a large control cohort without cryopreservation including 4133 BMTs and 720 PBSCTs. Among the patients with cryopreserved grafts, 10 BMT recipients (4.3%) and 3 PBSCT recipients (2.5%) did not achieve neutrophil engraftment after transplantation, including 4 of the former and all 3 of the latter who died early before engraftment. In a multivariate analysis, cryopreservation was not associated with neutrophil engraftment in BMT but significantly delayed neutrophil engraftment in PBSCT (hazard ratio [HR], .82; 95% confidence interval [CI], .69 to .97; P = .023). There was an interaction with borderline significance between cryopreservation and the stem cell source (P = .067). Platelet engraftment was delayed by cryopreservation after both BMT and PBSCT. Only 2 cryopreserved grafts (<1%) were unused during the study period. The cryopreservation of unrelated donor BM and PBSC grafts is associated with a slight delay in neutrophil and platelet engraftment but an acceptable rate of graft failure. PBSC grafts may be more sensitive to cryopreservation than BM grafts. Cryopreservation is a reasonable option during COVID-19 pandemic, provided that the apheresis and transplantation centers are adept at cryopreservation. © 2022 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peripheral Blood Stem Cell Transplantation / COVID-19 / Graft vs Host Disease Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte / Asia Language: En Journal: Transplant Cell Ther Year: 2022 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peripheral Blood Stem Cell Transplantation / COVID-19 / Graft vs Host Disease Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte / Asia Language: En Journal: Transplant Cell Ther Year: 2022 Document type: Article Country of publication: United States